留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

高脂血症性胰腺炎研究进展

赵慧佳 吴东 吴文铭

赵慧佳, 吴东, 吴文铭. 高脂血症性胰腺炎研究进展[J]. 协和医学杂志. doi: 10.12290/xhyxzz.2021-0760
引用本文: 赵慧佳, 吴东, 吴文铭. 高脂血症性胰腺炎研究进展[J]. 协和医学杂志. doi: 10.12290/xhyxzz.2021-0760
ZHAO Huijia, WU Dong, WU Wenming. Advances of Hyperlipidemic Pancreatitis[J]. Medical Journal of Peking Union Medical College Hospital. doi: 10.12290/xhyxzz.2021-0760
Citation: ZHAO Huijia, WU Dong, WU Wenming. Advances of Hyperlipidemic Pancreatitis[J]. Medical Journal of Peking Union Medical College Hospital. doi: 10.12290/xhyxzz.2021-0760

高脂血症性胰腺炎研究进展

doi: 10.12290/xhyxzz.2021-0760
详细信息
    通讯作者:

    吴文铭,E-mail:wuwm@pumch.cn

  • 中图分类号: R657.5+1;R576

Advances of Hyperlipidemic Pancreatitis

  • 摘要: 高脂血症性胰腺炎(hyperlipidemic pancreatitis,HLP)是急性胰腺炎 的重要病因之一,其发病机制主要与游离脂肪酸累积和炎症反应激活有关。HLP 的临床表现较其他病因的急性胰腺炎症状更重、并发症更多、持续性器官衰竭可 能性更高、更易复发等特点。HLP 的治疗需采用血浆置换或胰岛素注射等降脂治 疗以达到快速降低血清甘油三酯的效果。评估急性胰腺炎患者是否存在高脂血症 并作出及时处理,对于HLP 患者的预后和预防复发至关重要。本文将对HLP 的 流行病学、病因、发病机制、临床表现及治疗进展等进行阐述,以期为HLP 的 临床诊治提供借鉴和参考。
  • [1] Zhu Y, Pan X, Zeng H, et al. A Study on the Etiology, Severity, and Mortality of 3260 Patients With Acute Pancreatitis According to the Revised Atlanta Classification in Jiangxi, China Over an 8-Year Period. Pancreas, 2017. 46:504-509.
    [2] Li X, Ke L, Dong J, et al. Significantly different clinical features between hypertriglyceridemia and biliary acute pancreatitis:a retrospective study of 730 patients from a tertiary center. BMC Gastroenterol, 2018. 18:89.
    [3] Eckel R H,Cornier M A. Update on the NCEP ATP-III emerging cardiometabolic risk factors. BMC Med, 2014. 12:115.
    [4] Zheng C B, Zheng Z H,Zheng Y P. Therapeutic plasma exchange for hyperlipidemic pancreatitis:Current evidence and unmet needs. World J Clin Cases, 2021. 9:5794-5803.
    [5] Jin M, Bai X, Chen X, et al. A 16-year trend of etiology in acute pancreatitis:The increasing proportion of hypertriglyceridemia-associated acute pancreatitis and its adverse effect on prognosis. J Clin Lipidol, 2019. 13:947-953.e1.
    [6] Nawaz H, Koutroumpakis E, Easler J, et al. Elevated serum triglycerides are independently associated with persistent organ failure in acute pancreatitis. Am J Gastroenterol, 2015. 110:1497-503.
    [7] Jo S I, Chang J H, Kim T H, et al. Subsets associated with developing acute pancreatitis in patients with severe hypertriglyceridemia and the severity of pancreatitis. Pancreatology, 2019. 19:795-800.
    [8] Li Q, Hou C, Peng Y, et al. Diabetes and Younger Age Are Vital and Independent Risk Factors for Acute Pancreatitis in Patients with Severe Hypertriglyceridemia. Biomed Res Int, 2019. 2019:2620750.
    [9] Fredrickson D S. An international classification of hyperlipidemias and hyperlipoproteinemias. Ann Intern Med, 1971. 75:471-2.
    [10] Wang L, Xu T, Wang R, et al. Hypertriglyceridemia Acute Pancreatitis:Animal Experiment Research. Dig Dis Sci, 2021.
    [11] Paquette M, Hegele R A, Paré G, et al. A novel mutation in GPIHBP1 causes familial chylomicronemia syndrome. J Clin Lipidol, 2018. 12:506-510.
    [12] Hernandez P, Passi N, Modarressi T, et al. Clinical Management of Hypertriglyceridemia in the Prevention of Cardiovascular Disease and Pancreatitis. Curr Atheroscler Rep, 2021. 23:72.
    [13] Sun X, Zhou X, Dong B, et al. Generation of a gene-corrected isogenic iPSC line (AHQUi001-A- 1) from a patient with familial hypertriglyceridemia (FHTG) carrying a heterozygous p.C310R (c.928 T > C) mutation in LPL gene using CRISPR/Cas9. Stem Cell Res, 2021. 52:102230.
    [14] Simha V. Management of hypertriglyceridemia. BMJ, 2020. 371:m3109.
    [15] Yuan G, Al-Shali K Z,Hegele R A. Hypertriglyceridemia:its etiology, effects and treatment. CMAJ, 2007. 176:1113-20.
    [16] Eichenbaum-Voline S, Olivier M, Jones E L, et al. Linkage and association between distinct variants of the APOA1/C3/A4/A5 gene cluster and familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol, 2004. 24:167-74.
    [17] Chang Y T, Chang M C, Su T C, et al. Association of cystic fibrosis transmembrane conductance regulator (CFTR) mutation/variant/haplotype and tumor necrosis factor (TNF) promoter polymorphism in hyperlipidemic pancreatitis. Clin Chem, 2008. 54:131-8.
    [18] Ivanova R, Puerta S, Garrido A, et al. Triglyceride levels and apolipoprotein E polymorphism in patients with acute pancreatitis. Hepatobiliary Pancreat Dis Int, 2012. 11:96-101.
    [19] Cruciat G, Nemeti G, Goidescu I, et al. Hypertriglyceridemia triggered acute pancreatitis in pregnancy-diagnostic approach, management and follow-up care. Lipids Health Dis, 2020. 19:2.
    [20] Yang A L,McNabb-Baltar J. Hypertriglyceridemia and acute pancreatitis. Pancreatology, 2020. 20:795-800.
    [21] Valdivielso P, Ramírez-Bueno A,Ewald N. Current knowledge of hypertriglyceridemic pancreatitis. Eur J Intern Med, 2014. 25:689-94.
    [22] Hu X, Gong L, Zhou R, et al. Variations in Gut Microbiome are Associated with Prognosis of Hypertriglyceridemia-Associated Acute Pancreatitis. Biomolecules, 2021. 11.
    [23] Le Chatelier E, Nielsen T, Qin J, et al. Richness of human gut microbiome correlates with metabolic markers. Nature, 2013. 500:541-6.
    [24] 李非,曹锋. 中国急性胰腺炎诊治指南(2021). 中国实用外科杂志, 2021. 41:739-746.
    [25] Carr R A, Rejowski B J, Cote G A, et al. Systematic review of hypertriglyceridemia-induced acute pancreatitis:A more virulent etiology? Pancreatology, 2016. 16:469-76.
    [26] Wang Q, Wang G, Qiu Z, et al. Elevated Serum Triglycerides in the Prognostic Assessment of Acute Pancreatitis:A Systematic Review and Meta-Analysis of Observational Studies. J Clin Gastroenterol, 2017. 51:586-593.
    [27] He W H, Zhu Y, Zhu Y, et al.[Comparison of severity and clinical outcomes between hypertriglyceridemic pancreatitis and acute pancreatitis due to other causes]. Zhonghua Yi Xue Za Zhi, 2016. 96:2569-72.
    [28] Pascual I, Sanahuja A, García N, et al. Association of elevated serum triglyceride levels with a more severe course of acute pancreatitis:Cohort analysis of 1457 patients. Pancreatology, 2019. 19:623-629.
    [29] Anderson F, Thomson S R, Clarke D L, et al. Dyslipidaemic pancreatitis clinical assessment and analysis of disease severity and outcomes. Pancreatology, 2009. 9:252-7.
    [30] Zhang R, Deng L, Jin T, et al. Hypertriglyceridaemia-associated acute pancreatitis:diagnosis and impact on severity. HPB (Oxford), 2019. 21:1240-1249.
    [31] Zafrir B, Saliba W, Jubran A, et al. Severe Hypertriglyceridemia-Related Pancreatitis:Characteristics and Predictors of Recurrence. Pancreas, 2019. 48:182-186.
    [32] Wu B U, Batech M, Dong E Y, et al. Influence of Ambulatory Triglyceride Levels on Risk ofRecurrence in Patients with Hypertriglyceridemic Pancreatitis. Dig Dis Sci, 2019. 64:890-897.
    [33] Vipperla K, Somerville C, Furlan A, et al. Clinical Profile and Natural Course in a Large Cohort of Patients With Hypertriglyceridemia and Pancreatitis. J Clin Gastroenterol, 2017. 51:77-85.
    [34] 高甘油三酯血症性急性胰腺炎诊治急诊共识专家组. 高甘油三酯血症性急性胰腺炎诊治急诊专家共识中华急诊医学杂志, 2021. 30:937-947.
    [35] Garg R,Rustagi T. Management of Hypertriglyceridemia Induced Acute Pancreatitis. Biomed Res Int, 2018. 2018:4721357.
    [36] Chen J H, Yeh J H, Lai H W, et al. Therapeutic plasma exchange in patients with hyperlipidemic pancreatitis. World J Gastroenterol, 2004. 10:2272-4.
    [37] Gubensek J, Buturovic-Ponikvar J, Romozi K, et al. Factors affecting outcome in acute hypertriglyceridemic pancreatitis treated with plasma exchange:an observational cohort study. PLoS One, 2014. 9:e102748.
    [38] Berberich A J, Ziada A, Zou G Y, et al. Conservative management in hypertriglyceridemiaassociated pancreatitis. J Intern Med, 2019. 286:644-650.
    [39] Coskun A, Erkan N, Yakan S, et al. Treatment of hypertriglyceridemia-induced acute pancreatitis with insulin. Prz Gastroenterol, 2015. 10:18-22.
    [40] Li J, Chen T R, Gong H L, et al. Intensive insulin therapy in severe acute pancreatitis:a metaanalysis and systematic review. West Indian Med J, 2012. 61:574-9.
    [41] Jin M, Peng J M, Zhu H D, et al. Continuous intravenous infusion of insulin and heparin vs plasma exchange in hypertriglyceridemia-induced acute pancreatitis. J Dig Dis, 2018. 19:766-772.
    [42] He W H, Yu M, Zhu Y, et al. Emergent Triglyceride-lowering Therapy With Early High-volume Hemofiltration Against Low-Molecular-Weight Heparin Combined With Insulin in Hypertriglyceridemic Pancreatitis:A Prospective Randomized Controlled Trial. J Clin Gastroenterol, 2016. 50:772-8.
  • 加载中
计量
  • 文章访问数:  61
  • HTML全文浏览量:  3
  • PDF下载量:  7
  • 被引次数: 0
出版历程
  • 收稿日期:  2021-11-29
  • 网络出版日期:  2022-03-09

目录

    /

    返回文章
    返回